(Q45573898)

English

Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system.

scientific article published on 18 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

0 references

Crohn's disease

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Patrizia Brigidi

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Adele Costabile

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Simone Maccaferri

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Beatrice Vitali

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Annett Klinder

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Sofia Kolida

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Maurice Ndagijimana

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Fiorella Calanni

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Glenn R Gibson

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

0 references

publication date

18 September 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

65

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

2556-2565

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Microbial host interactions in IBD: implications for pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Host-bacterial mutualism in the human intestine

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

The role of antibiotics in the management of Crohn's disease

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Rifaximin: a review of its use in the management of traveller's diarrhoea

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Management of diverticular disease: is there room for rifaximin?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

An open-label evaluation of rifaximin in the treatment of active Crohn's disease

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

The role of gut microbiota in drug response.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Validation of a Three-Stage Compound Continuous Culture System for Investigating the Effect of Retention Time on the Ecology and Metabolism of Bacteria in the Human Colon

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gut.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Effect of fermentable carbohydrates on piglet faecal bacterial communities as revealed by denaturing gradient gel electrophoresis analysis of 16S ribosomal DNA.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

A simple technique for quantitation of low levels of DNA damage in individual cells

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Different fecal microbiotas and volatile organic compounds in treated and untreated children with celiac disease

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by (1)H Nuclear Magnetic Resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Unravelling the pathogenesis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Understanding why probiotic therapies can be effective in treating IBD.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Genome-scale analyses of health-promoting bacteria: probiogenomics

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Phylogenetic relationships of butyrate-producing bacteria from the human gut.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

In vitro activity and fecal concentration of rifaximin after oral administration

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Involvement of central immunity in uncomplicated diverticular disease

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

The butyrate story: old wine in new bottles?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Review article: prebiotics in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Panorganismal gut microbiome-host metabolic crosstalk

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ345

21 January 2018

Identifiers

10.1093/JAC/DKQ345

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20852272%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45573898&oldid=1402250688"